MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202617086943 A) filed by Fortvita Biologics Singapore Pte. Ltd. on July 16, 2026, for Bispecific Antibody-Drug Conjugates Targeting B7h3 And Egfr And The Use Thereof.
Inventors include He, Kaijie; Zhang, Xiao; Guan, Jian; and Zhou, Shuaixiang.
The application for the patent was published on October 09, 2026, under issue no. 41/2026.
Abstract: Bispecific antibody-drug conjugates (ADCs) targeting B7H3 and EGFR and compositions containing the same are provided. Therapeutic and diagnostic uses of these antibodies and antibody fragments are also provided.
Disclaimer: Curated by HT Syndication....